Page 24 - Read Online

74. Tamada M, Suematsu M, Saya H. Pyruvate kinase M2: for cancer. Anticancer Agents Med Chem 2014;14:280-9.
multiple faces for conferring benefi ts on cancer cells. Clin 90. Wang Z, Liang S, Lian X, Liu L, Zhao S, Xuan Q, Guo L,
Cancer Res 2012;18:5554-61. Liu H, Yang Y, Dong T, Liu Y, Liu Z, Zhang Q. Identifi cation
75. Kaplon J, Zheng L, Meissl K, Chaneton B, Selivanov VA, of proteins responsible for adriamycin resistance in breast
Mackay G, van der Burg SH, Verdegaal EM, Cascante M, cancer cells using proteomics analysis. Sci Rep 2015;5:9301.
Shlomi T, Gottlieb E, Peeper DS. A key role for mitochondrial 91. Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC,
gatekeeper pyruvate dehydrogenase in oncogene-induced Fletcher-Sananikone E, Locasale JW, Son J, Zhang H,
senescence. Nature 2013;498:109-12. Coloff JL, Yan H, Wang W, Chen S, Viale A, Zheng H,
76. Hur H, Xuan Y, Kim YB, Lee G, Shim W, Yun J, Ham IH, Paik JH, Lim C, Guimaraes AR, Martin ES, Chang J, Hezel AF,
Han SU. Expression of pyruvate dehydrogenase kinase-1 in Perry SR, Hu J, Gan B, Xiao Y, Asara JM, Weissleder R,
gastric cancer as a potential therapeutic target. Int J Oncol Wang YA, Chin L, Cantley LC, DePinho RA. Oncogenic Kras
2013;42:44-54. maintains pancreatic tumors through regulation of anabolic
77. Lu CW, Lin SC, Chien CW, Lin SC, Lee CT, Lin BW, Lee JC, glucose metabolism. Cell 2012;149:656-70.
Tsai SJ. Overexpression of pyruvate dehydrogenase kinase 92. Duvel K, Yecies JL, Menon S, Raman P, Lipovsky AI,
3 increases drug resistance and early recurrence in colon Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S,
cancer. Am J Pathol 2011;179:1405-14. Vander Heiden MG, MacKeigan JP, Finan PM, Clish CB,
78. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A Murphy LO, Manning BD. Activation of a metabolic gene
expression uncovers a link between glycolysis, mitochondrial regulatory network downstream of mTOR complex 1. Mol Cell
physiology, and tumor maintenance. Cancer Cell 2010;39:171-83.
2006;9:425-34. 93. Jiang P, Du W, Yang X. A critical role of glucose-6-phosphate
79. Goldman RD, Kaplan NO, Hall TC. Lactic dehydrogenase in dehydrogenase in TAp73-mediated cell proliferation.
human neoplastic tissues. Cancer Res 1964;24:389-99. Cell Cycle 2013;12:3720-6.
80. Zhang Y, Zhang X, Wang X, Gan L, Yu G, Chen Y, 94. Du W, Jiang P, Mancuso A, Stonestrom A, Brewer MD,
Liu K, Li P, Pan J, Wang J, Qin S. Inhibition of LDH-A Minn AJ, Mak TW, Wu M, Yang X. TAp73 enhances the
by lentivirus-mediated small interfering RNA suppresses pentose phosphate pathway and supports cell proliferation. Nat
intestinal-type gastric cancer tumorigenicity through the Cell Biol 2013;15:991-1000.
downregulation of Oct4. Cancer Lett 2012;321:45-54. 95. Cosentino C, Grieco D, Costanzo V. ATM activates the
81. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, pentose phosphate pathway promoting anti-oxidant defence
Harris AL, Tumour Angiogenesis Research Group. Lactate and DNA repair. EMBO J 2011;30:546-55.
dehydrogenase 5 expression in operable colorectal cancer: 96. Hong X, Song R, Song H, Zheng T, Wang J, Liang Y, Qi S,
strong association with survival and activated vascular Lu Z, Song X, Jiang H, Liu L, Zhang Z. PTEN antagonises
endothelial growth factor pathway-A report of the Tumour Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which
Angiogenesis Research Group. J Clin Oncol 2006;24:4301-8. contributes to hepatocarcinogenesis. Gut 2014;63:1635-47.
82. Fan J, Hitosugi T, Chung TW, Xie J, Ge Q, Gu TL, 97. Leopold JA, Dam A, Maron BA, Scribner AW, Liao R,
Polakiewicz RD, Chen GZ, Boggon TJ, Lonial S, Khuri FR, Handy DE, Stanton RC, Pitt B, Loscalzo J. Aldosterone
Kang S, Chen J. Tyrosine phosphorylation of lactate impairs vascular reactivity by decreasing glucose-6-phosphate
dehydrogenase A is important for NADH/NAD(+) redox dehydrogenase activity. Nat Med 2007;13:189-97.
homeostasis in cancer cells. Mol Cell Biol 2011;31:4938-50. 98. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T,
83. Sheng SL, Liu JJ, Dai YH, Sun XG, Xiong XP, Huang G. Aburatani H, Yamamoto M, Motohashi H. Nrf2 redirects
Knockdown of lactate dehydrogenase A suppresses tumor glucose and glutamine into anabolic pathways in metabolic
growth and metastasis of human hepatocellular carcinoma. reprogramming. Cancer Cell 2012;22:66-79.
FEBS J 2012;279:3898-910. 99. Wu KC, Cui JY, Klaassen CD. Benefi cial role of Nrf2 in
84. Jiang P, Du W, Wu M. Regulation of the pentose phosphate regulating NADPH generation and consumption. Toxicol Sci
pathway in cancer. Protein Cell 2014;5:592-602. 2011;123:590-600.
85. Kletzien RF, Harris PK, Foellmi LA. Glucose-6-phosphate 100. Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y,
dehydrogenase: a “housekeeping” enzyme subject to Chiba T, Igarashi K, Yamamoto M. Oxidative stress sensor
tissue-specifi c regulation by hormones, nutrients, and oxidant Keap1 functions as an adaptor for Cul3-based E3 ligase to
stress. FASEB J 1994;8:174-81. regulate proteasomal degradation of Nrf2. Mol Cell Biol
86. Tsouko E, Khan AS, White MA, Han JJ, Shi Y, Merchant FA, 2004;24:7130-9.
Sharpe MA, Xin L, Frigo DE. Regulation of the pentose 101. Jaramillo MC, Zhang DD. The emerging role of the
phosphate pathway by an androgen receptor-mTOR-mediated Nrf2-Keap1 signaling pathway in cancer. Genes Dev
mechanism and its role in prostate cancer cell growth. 2013;27:2179-91.
Oncogenesis 2014;3:e103. 102. Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC,
87. Wang J, Yuan W, Chen Z, Wu S, Chen J, Ge J, Hou F, Chen Z. Moran CA, Corvalan AH, Biswal S, Swisher SG,
Overexpression of G6PD is associated with poor clinical Bekele BN, Minna JD, Stewart DJ, Wistuba II. Nrf2 and
outcome in gastric cancer. Tumour Biol 2012;33:95-101. Keap1 abnormalities in non-small cell lung carcinoma and
88. Lucarelli G, Galleggiante V, Rutigliano M, Sanguedolce F, association with clinicopathologic features. Clin Cancer Res
Cagiano S, Bufo P, Lastilla G, Maiorano E, Ribatti D, 2010;16:3743-53.
Giglio A, Serino G, Vavallo A, Bettocchi C, Selvaggi FP, 103. Fer ND, Shoemaker RH, Monks A. Adaphostin toxicity in a
Battaglia M, Ditonno P. Metabolomic profi le of glycolysis sensitive non-small cell lung cancer model is mediated through
and the pentose phosphate pathway identifi es the central role Nrf2 signaling and heme oxygenase 1. J Exp Clin Cancer Res
of glucose-6-phosphate dehydrogenase in clear cell-renal cell 2010;29:91.
carcinoma. Oncotarget 2015;6:13371-86. 104. Martinez VD, Vucic EA, Thu KL, Pikor LA, Lam S,
89. Zhang C, Zhang Z, Zhu Y, Qin S. Glucose-6-phosphate Lam WL. Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin
dehydrogenase: a biomarker and potential therapeutic target ligase complex components by multiple genetic mechanisms:

180 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦